Breaking News on Global Pharmaceutical Technology & Manufacturing

Delivery formulations

News headlines

‘First liquid aspirin’ maker seeks licensing deal

01-Oct-2015 - Innovate Pharmaceuticals has launched what it claims is the world’s first shelf-stable liquid aspirin, and says it is on the look-out for a licensing partner for the “$500m” market.

Heptares awarded NIH grant to tackle cocaine addiction

29-Sep-2015 - Blocking the neuropeptides that regulate arousal and appetite could lead to a treatment for cocaine addiction, says Heptares which has received an NIH development grant.

Polpharma hires ex Lupin, Teva and Merck KGaA man to lead biosimilar push

29-Sep-2015 - Polpharma has continued its biosimilar-focused hiring spree and appointed Maurice Chagnaud as its CEO.

Evonik hikes up pharma excipient prices

28-Sep-2015 - Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.

Potential $1.25bn deal adds CEPT inhibitor to Amgen's cardiovascular offerings

22-Sep-2015 - Amgen could pay up to $1.25bn Dezima Pharma if its promising lead candidate - the cholesterol buster TA-8995 - is approved.

Glide and Cilian team to develop solid dose flu vaccine

22-Sep-2015 - Cilian has teamed up with Glide Technologies to develop a solid dose influenza vaccine to be delivered via a needle-free injector.

Police Facebook campaign calls on high-paid Pharma CEOs to tackle opioid abuse

21-Sep-2015 - A Massachusetts-based police department has published contact and salary details of Big Pharma CEOs in an effort to force industry to help manage opiate addiction.


Sun Pharma eyes US ocular delivery expert

16-Sep-2015 - Indian generics company Sun Pharma has made a $48m (€42m) offer for US eye drug maker InSite Vision and its delivery platform.

Supersonic spray will transform bioavailability, says BASF

15-Sep-2015 - BASF is developing extra-soluble nanoparticles for better drug delivery using faster-than-sound technology.

Midatech revenues up 800% on gold nanoparticle drug conjugate tech

15-Sep-2015 - Midatech’s gold nanoparticle (GNP) drug conjugate technology and recent acquisitions are helping transfer the firm into a speciality pharma company, an analyst says.

GSK starts work on $153m anti inflammatories and gastro drug plant in India

09-Sep-2015 - GSK has started work on an anti-inflammatory and gastrointestinal drug production plant in Vemgal, India which will create 300 manufacturing jobs.

Novo Nordisk and MIT on the hunt for oral peptide route

08-Sep-2015 - Novo Nordisk is collaborating with MIT on new ways to deliver peptides.

AstraZeneca signs dendrimer drug delivery deal with Australian tech firm

07-Sep-2015 - AstraZeneca has licensed Starpharma’s Dendrimer Drug Delivery (DEP) platform to enhance the pharmaceutical properties in candidates in its oncology pipeline.

CeQur's $100m financing to scale-up insulin delivery patch-pump production

03-Sep-2015 - GLP-1 drugs and oral formulations will not diminish demand for insulin patch-pumps says CeQur, which has raised $100m (€89m) to support production of its PaQ delivery device.

Sanofi seeks to expand UK inhalables site with an eye on CMO business

03-Sep-2015 - Sanofi wants to expand its inhalable drug production site in Cheshire, UK to increase capacity for both its own brand drug production operations and its contract manufacturing business.

NIPER says API nano crystal formulation tech will cut drug costs

02-Sep-2015 - The National Institute of Pharmaceutical Education and Research (NIPER ) in India has created and licensed technology for producing nano-crystal based medicines that it says will cut drug costs.  

Europe, US, Japan: The recall round-up

27-Aug-2015 - Product problems for Allergan and Danish Leo Pharma, plus the Japanese regulator reviews a Bristol-Myers Squibb mAb.

Novo Nordisk to pump $2bn into diabetes network on back of oral GLP-1 milestone

27-Aug-2015 - Novo Nordisk could spend up to $2bn (€1.8bn) on two facilities to support its diabetes portfolio, including an oral long-acting GLP-1 analogue set to enter Phase III trials.

Device advice: Intertek study shows its key to consider devices in formulation development

26-Aug-2015 - Pharma firms developing inhalable drugs often fail to test that their formulations are compatible with their intended delivery devices early enough according to the Intertek team behind research stressing the benefits of early assessment.

Xellia moves US HQ to North Carolina

20-Aug-2015 - Anti-infectives firm Xellia has moved its North American HQ to the lyophilisation plant in Raleigh, North Carolina that it bought from Fresenius Kabi last July .

Related News

Key Industry Events


Access all events listing

Our events, Shows & Conferences...

Product Innovation